Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 54.70
+0.20 (0.37%)
At close: Aug 11, 2025
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 5.88 billion as of August 12, 2025. Its market cap has decreased by -38.95% in one year.
Market Cap
5.88B
Enterprise Value
10.61B
Revenue
8.47B
Ranking
n/a
PE Ratio
13.12
Stock Price
54.70
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 5.88B, an increase of 107.20%. That is a compound annual growth rate of 29.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 5.88B | 12.55% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grameenphone | 426.29B |
| Square Pharmaceuticals PLC. | 203.53B |
| British American Tobacco Bangladesh Company | 158.98B |
| Robi Axiata PLC. | 142.47B |
| BRAC Bank PLC. | 135.78B |
| Walton Hi-Tech Industries | 135.56B |
| Bangladesh Export Import Company | 103.85B |
| Marico Bangladesh | 92.34B |